Travelling with Aspergillosis: A Comprehensive Guide to Safe and Stable Travel

This guide is for people living with:

  • Chronic Pulmonary Aspergillosis (CPA)
  • Allergic Bronchopulmonary Aspergillosis (ABPA)
  • Severe asthma (including fungal sensitisation)
  • Bronchiectasis
  • Fibrotic or structurally abnormal lung disease

Most people with stable disease can travel successfully. The goal is not restriction — it is risk reduction through preparation, environmental awareness, and early action if symptoms change.

Contents

1. Understanding Travel Risk in Aspergillosis

Travel risk arises from four domains:

  1. Structural lung vulnerability (cavities, fibrosis, bronchiectasis)
  2. Inflammatory instability (ABPA activity, asthma control)
  3. Environmental exposure (humidity, dust, pollution)
  4. Healthcare accessibility (if deterioration occurs)

Travel is usually safe when disease is stable and exposures are predictable.

2. Coordinating With Your Medical Team

Respiratory Clinic

  • Review recent imaging (particularly in CPA)
  • Assess haemoptysis history
  • Consider fit-to-fly testing if oxygen saturation borderline
  • Discuss standby rescue medication

GP

  • Ensure medication supply exceeds travel duration
  • Provide updated medication summary
  • Support vaccination review
  • Assist with insurance documentation

3. Assessing Stability Before Travel

Delay travel if within 4–6 weeks of:

  • Significant haemoptysis
  • Escalating breathlessness
  • Recent hospital admission
  • New antifungal initiation

Stable inflammatory markers and symptom plateau are reassuring.

4. Choosing a Destination: Environmental Determinants

Key determinants:

  • Humidity: promotes indoor mould growth
  • Flood history: water damage increases fungal load
  • Air pollution: triggers bronchospasm
  • Dust burden: irritates inflamed airways
  • Healthcare infrastructure: safety net if unwell

5. Regional Risk Patterns Explained

Lower Overall Respiratory Stress

  • Scandinavia
  • New Zealand
  • Canada (outside wildfire season)

Cooler climates limit mould growth; strong building codes reduce damp housing.

Moderate Risk

  • Mediterranean Europe

Generally safe when stable; monitor wildfire smoke and heat stress.

Higher Respiratory Stress

  • Tropical monsoon climates
  • Flood-prone regions
  • Highly polluted megacities
  • Dust storm zones

Humidity increases fungal proliferation; particulate pollution worsens airway inflammation.

6. Air Pollution & AQI Monitoring

Air pollution can exacerbate cough, bronchospasm, breathlessness and fatigue in people with chronic lung disease. In some urban environments, pollution may pose a greater day-to-day risk than fungal exposure.

The most widely used measure of air quality is the Air Quality Index (AQI), which combines several pollutants into a single score.

Key Pollutants That Matter in Lung Disease

  • PM2.5 – fine particulate matter small enough to penetrate deep into the lungs
  • PM10 – larger inhalable particles
  • Ozone (O₃) – irritates airways, especially in heat
  • Nitrogen dioxide (NO₂) – associated with traffic pollution

PM2.5 is particularly important in aspergillosis and severe asthma because it can:

  • Trigger airway inflammation
  • Increase mucus production
  • Worsen bronchospasm
  • Reduce exercise tolerance

Reliable Air Quality Monitoring Resources

These sites provide real-time data and forecasts:

  • World Air Quality Index (WAQI)
    https://waqi.info
    Interactive global map with live AQI data for cities worldwide.
  • IQAir (AirVisual)
    https://www.iqair.com
    Detailed pollutant breakdowns, 7-day forecasts and wildfire smoke tracking.
  • UK Daily Air Quality Index (DEFRA)
    https://uk-air.defra.gov.uk
    Official UK monitoring network with health advice bands.

These platforms also offer mobile apps, which are useful for checking conditions while travelling.

How to Interpret AQI in Practical Terms

AQI Category Practical Advice for Lung Conditions
0–50 Good Ideal conditions for outdoor activity
51–100 Moderate Usually safe; monitor symptoms
101–150 Unhealthy for sensitive groups Reduce strenuous outdoor activity; consider indoor plans
151–200 Unhealthy Limit time outdoors; avoid exertion
200+ Very Unhealthy/Hazardous Stay indoors with filtered air if possible

For many patients with CPA, ABPA or severe asthma, an AQI above 100 warrants caution. Above 150, limiting outdoor exposure is advisable.

Wildfire Smoke

Wildfire smoke contains high concentrations of PM2.5 and organic particulates. Even patients who are stable at home may experience:

  • Increased cough
  • Chest tightness
  • Increased sputum production
  • Fatigue

If travelling during wildfire season:

  • Check AQI daily
  • Plan indoor activities when levels are elevated
  • Use air-conditioned or filtered indoor environments
  • Carry rescue inhalers

Urban Pollution vs Rural Dust

Urban areas are more affected by traffic-related pollutants (NO₂, PM2.5), while rural or desert areas may present dust exposure. Both can aggravate inflamed airways.

The risk is cumulative. Short exposure is usually tolerated; prolonged high-level exposure increases the likelihood of symptom flare.

Key principle: checking AQI before and during travel is one of the simplest and most effective risk-reduction steps for people with chronic lung disease.

7. Heat, Humidity & Hydration Physiology

Hot climates place additional physiological stress on people with chronic lung disease.

Why Heat Matters

In warm environments, the body increases sweating and respiratory water loss to regulate temperature. This leads to:

  • Increased insensible fluid loss (fluid lost through breathing and skin)
  • Reduced plasma volume if intake is inadequate
  • Thickening of airway secretions

In bronchiectasis and chronic pulmonary aspergillosis (CPA), mucus clearance is already impaired. Dehydration increases mucus viscosity, making sputum:

  • Harder to expectorate
  • More likely to stagnate in damaged airways
  • Potentially more prone to secondary infection

Patients may notice thicker sputum, increased cough, or chest tightness in hot weather.

Humidity: Helpful or Harmful?

Humidity has mixed effects:

  • Moderate humidity can help prevent airway drying.
  • High humidity can increase environmental mould growth, particularly indoors if ventilation is poor.

In tropical or monsoon climates, poorly ventilated buildings may have higher fungal spore burdens due to damp conditions.

Heat, Fatigue & Breathlessness

Heat increases cardiovascular demand. The heart works harder to dissipate heat, which can:

  • Increase perceived breathlessness
  • Increase fatigue
  • Reduce exercise tolerance

This does not necessarily indicate worsening lung disease — but it can feel similar.

Hydration Strategy

Practical recommendations:

  • Begin hydrating the day before travel
  • Drink fluids regularly rather than waiting for thirst
  • Aim for pale straw-coloured urine
  • Increase intake during flights and hot excursions

Limit:

  • Excess alcohol (diuretic effect)
  • High caffeine intake

Additional Practical Measures

  • Plan outdoor activity early morning or evening
  • Rest during peak heat (midday)
  • Use air-conditioned environments when available
  • Continue airway clearance routines while travelling

Key principle: in chronic lung disease, hydration supports mucus clearance and reduces avoidable exacerbation risk during hot weather.

8. Travel Insurance & Full Medical Disclosure

Travel insurance is not a formality — it is a critical safety net for people with chronic lung disease.

When purchasing insurance, you must declare all pre-existing medical conditions. This typically includes:

  • Chronic Pulmonary Aspergillosis (CPA)
  • Allergic Bronchopulmonary Aspergillosis (ABPA)
  • Severe asthma
  • Bronchiectasis
  • Pulmonary fibrosis
  • Long-term steroid therapy
  • Adrenal insufficiency (if present)
  • Oxygen use (even if only occasional)

Why Full Disclosure Matters

If you fail to declare a relevant condition, the insurer may:

  • Refuse to cover medical treatment abroad
  • Decline repatriation costs
  • Refuse to reimburse cancelled flights or accommodation
  • Invalidate the entire policy

This applies even if the emergency appears unrelated. Insurers may review your full medical history during a claim.

What Insurers Typically Ask

You may be asked:

  • Have you been hospitalised in the past 12 months?
  • Have you had medication changes recently?
  • Have you had haemoptysis?
  • Are you awaiting tests or investigations?
  • Are you on long-term steroids?

Answer these questions carefully and honestly.

Policies and Stability

Some insurers will decline cover if:

  • You have been hospitalised recently
  • You are awaiting investigations
  • Your condition is considered unstable

This is another reason to travel during a period of clinical stability.

European Travel (UK Patients)

If travelling within Europe, ensure you carry:

  • Your GHIC (Global Health Insurance Card)

However, GHIC does not replace travel insurance. It may not cover:

  • Private healthcare
  • Mountain rescue
  • Repatriation to the UK

Practical Tips

  • Purchase insurance as soon as you book travel
  • Keep written confirmation of declared conditions
  • Carry the insurer’s emergency contact number with you
  • Inform the insurer early if you require hospital care abroad

In summary: full disclosure protects you. Insurance is only effective if the insurer understands your medical background from the outset.

9. Medication Planning & Contingency Prescriptions

  • Carry 1–2 weeks extra supply
  • Bring medications in original packaging
  • Carry clinic letter
  • Consider written rescue plan

10. Specific Considerations for Azole Antifungals

Azoles have significant drug–drug interactions.

  • Inform any clinician abroad you are taking an azole
  • Avoid grapefruit
  • Be aware of sun sensitivity (voriconazole)
  • Take itraconazole with food

11. Air Travel: What Actually Happens in the Cabin?

Commercial aircraft cabins are pressurised to simulate an altitude of approximately 6,000–8,000 feet (1,800–2,400 metres).

This means the partial pressure of oxygen is lower than at sea level. For healthy individuals this causes only a small drop in oxygen saturation (typically 3–4%).

Are Most People with Aspergillosis OK to Fly?

Yes — most stable patients fly without difficulty.

People who are:

  • Clinically stable
  • Not oxygen-dependent
  • Without recent haemoptysis
  • With resting oxygen saturations ≥95%

generally tolerate commercial flights well, including medium and long-haul travel.

Many patients report anxiety before their first flight after diagnosis, but in stable disease, significant problems are uncommon.

Who Should Consider Fit-to-Fly Testing?

Assessment may be appropriate if you have:

  • Resting oxygen saturation consistently below 95%
  • Advanced pulmonary fibrosis
  • Extensive cavitation
  • Significant breathlessness at minimal exertion
  • Recent clinical deterioration

The test commonly used is a Hypoxic Challenge Test (HCT), which simulates cabin oxygen conditions to determine whether supplemental oxygen is required during flight.

Where would I have a Hypoxic Challenge Test (HCT)?

In the UK, a Hypoxic Challenge Test is usually arranged through a hospital respiratory physiology department.

You cannot book this test directly. It must be requested by:

  • Your respiratory consultant or clinic, or
  • Occasionally your GP (who would refer you to a hospital service)

The test is typically performed in:

  • A hospital lung function laboratory
  • A respiratory physiology unit
  • A specialist respiratory centre

During the test, you breathe a gas mixture containing a lower oxygen concentration (usually around 15%) to simulate aircraft cabin conditions. Your oxygen saturation is monitored continuously. If levels fall below safe thresholds, in-flight oxygen may be recommended.

Do Most People Need This Test?

No. Many stable patients with normal resting oxygen saturation (typically ≥95%) do not require hypoxic challenge testing.

The test is generally considered if you:

  • Have resting oxygen saturation below 95%
  • Have advanced pulmonary fibrosis
  • Are already using oxygen
  • Have significant exertional desaturation

If you are unsure, ask your respiratory team whether assessment is appropriate for you.

Symptoms During Flight: What Is Normal?

Mild symptoms that can occur in stable patients include:

  • Slight increase in breathlessness on walking the aisle
  • Fatigue
  • Dry cough (often due to low humidity)

These are usually temporary and not dangerous.

Severe symptoms (marked breathlessness at rest, chest pain, dizziness, confusion) are uncommon and require crew notification.

Anxiety vs Physiological Breathlessness

It is very common for people with chronic lung disease to experience heightened awareness of their breathing during flights. The enclosed environment, reduced cabin pressure and awareness of altitude can all increase anxiety.

Anxiety-related breathlessness typically presents as:

  • A sensation of not getting a “satisfying” breath
  • Chest tightness without wheeze
  • Rapid breathing (hyperventilation)
  • Tingling in fingers or lips
  • Light-headedness

Hyperventilation lowers carbon dioxide levels in the blood. This can cause dizziness, tingling and a feeling of air hunger — even when oxygen levels are normal.

Physiological hypoxia (true low oxygen levels) is less common in stable patients who have been assessed as fit to fly. When it occurs, it is more likely in those with advanced fibrosis, low baseline oxygen saturations, or recent instability.

Features more suggestive of physiological compromise include:

  • Persistent breathlessness at rest
  • Worsening cyanosis (bluish lips or fingers)
  • Marked fatigue or confusion
  • Objective low oxygen saturation if measured

For patients who have undergone fit-to-fly assessment and been cleared to travel, significant in-flight hypoxia is uncommon.

Practical Strategies

  • Use slow, paced breathing (e.g. inhale for 4 seconds, exhale for 6 seconds)
  • Focus on extended exhalation to reduce hyperventilation
  • Keep shoulders relaxed and posture upright
  • Avoid repeatedly “checking” your breathing
  • Remind yourself that mild symptoms are common and expected

Understanding the difference between anxiety-related breathlessness and true hypoxia can significantly reduce distress during flight.

Deep Vein Thrombosis (DVT) Risk

Chronic lung disease does not automatically increase DVT risk, but long-haul immobility does.

General advice:

  • Move legs regularly
  • Stay hydrated
  • Avoid excess alcohol

12. Cabin Dryness & Post-Flight Airway Irritation

Cabin humidity is typically 10–20% (normal indoor comfort is 40–60%).

Low humidity can:

  • Dry airway lining
  • Reduce mucociliary clearance
  • Thicken secretions
  • Trigger cough or mild bronchospasm

This is often why people feel they have “caught a cold” the day after flying. In most cases, it is airway irritation rather than infection.

How to Reduce Dryness Effects

  • Hydrate well before and during flight
  • Limit alcohol and caffeine
  • Use isotonic saline nasal spray
  • Continue preventer inhalers
  • Keep rescue inhaler accessible
  • Avoid direct overhead air vents blowing onto your face
  • Consider mask use — masks increase humidity of inhaled air

Symptoms typically settle within 24–48 hours.

When to Seek Advice After Flying

Seek medical advice if you develop:

  • Progressively worsening breathlessness
  • Persistent fever
  • Significant haemoptysis
  • Chest pain

In stable patients, serious in-flight deterioration is uncommon.

12. Cabin Dryness & Post-Flight Irritation

Cabin humidity is 10–20%.

Dry air:

  • Reduces mucociliary clearance
  • Thickens secretions
  • Triggers cough
  • Irritates airways

Hydration and saline sprays reduce symptoms. Post-flight irritation commonly lasts 24–48 hours and does not necessarily indicate infection.

13. Travelling with Oxygen

Confirm airline device approval and battery duration. Plan well in advance.

14. Accommodation Risk Reduction

Request:

  • Hard flooring
  • No damp odour
  • No renovation dust
  • Pet-free rooms

Chains Often Reported as Allergy-Conscious

  • Hyatt
  • Hilton
  • Marriott
  • Scandic
  • Premier Inn

Newer business hotels often have better HVAC filtration.

15. High-Spore & Dust Exposure Environments

  • Compost handling
  • Construction sites
  • Flood-damaged buildings
  • Agricultural dust

Avoid heavy inhalation exposure.

16. Infection Prevention

  • Hand hygiene
  • Avoid close contact with visibly unwell individuals
  • Maintain vaccination schedule

17. Haemoptysis Planning

If you have a history of haemoptysis:

  • Know your previous pattern
  • Carry clinic contact details
  • Seek urgent care if volume increases significantly

18. Red Flag Symptoms

  • Increasing breathlessness
  • New or worsening haemoptysis
  • Persistent fever
  • Severe chest pain

19. Advanced Planning Checklist

  • Travel when stable
  • Plan with GP and respiratory clinic
  • Carry documentation
  • Monitor AQI
  • Hydrate on flights
  • Avoid damp & heavy dust
  • Know red flags

With preparation, most people with stable aspergillosis travel safely and successfully.

by GAtherton

Remediation, verification, and refusal to move you

Home › Knowledge Hub › Damp, mould and aspergillosis › Remediation & refusal to move

If remediation is done but symptoms persist or worsen, the key question becomes: has the home been demonstrated to be safe to occupy?

What “good remediation” should include

  • Cause fixed: leak/ingress/defect repaired, not just cleaned.
  • Drying: adequate drying time and moisture checks.
  • Material decisions: water-damaged porous materials removed where needed.
  • Safe work: dust/spore spread controlled (important for medically vulnerable households).
  • Verification: documented checks that work is complete and the home is safe.

Red flags (“bad remediation”)

  • Paint over staining or “mould spray” only
  • No drying plan, no moisture measurements
  • No documentation of what was removed/replaced
  • Work that creates dust without protection/containment
  • Refusal to provide any meaningful post-remediation checks

If symptoms worsen after remediation

Worsening symptoms can occur if contaminated materials were disturbed or if damp persists behind walls/floors. This is a strong indicator that the hazard may not be resolved.

Actions:

  1. Document symptoms and healthcare visits (Page 3 template).
  2. Ask landlord for written evidence of safety and remediation details.
  3. Request escalation to Environmental Health if unresolved.

If the landlord refuses to move you (decant)

Use this framing:

  • The issue is not “repairs completed” — it is safety and health risk.
  • Ask: “What evidence shows the home is safe to occupy?”

Template request for temporary alternative accommodation

Subject: Request for temporary alternative accommodation (health risk / damp and mould)

Hello [Name/Team],

Despite remediation work, we are experiencing ongoing damp/mould concerns and worsening health symptoms in a clinically vulnerable household.

Please provide written evidence that the home is safe to occupy, including:
- confirmation the moisture source has been resolved,
- evidence of drying/moisture checks,
- what materials were removed/replaced,
- what post-remediation checks were completed.

Given the uncertainty around safety and the health impacts, we are requesting temporary alternative accommodation until the property can be demonstrated to be safe to occupy.

Kind regards,
[Name]

If you return “under protest”

If you have no alternative but to return, keep it in writing:

We are returning to the property due to lack of alternative accommodation. We do not accept that the damp/mould hazard has been resolved and will continue to document health impacts and seek independent assessment.

by GAtherton

Trials, systematic reviews, and state-of-the-science reviews from ~2016–2026 on damp housing, mould, and health

Executive summary (what 10 years of evidence consistently shows)

1) Damp and mouldy housing is a causal driver of respiratory disease

  • Strong, repeated associations with asthma incidence, asthma exacerbations, wheeze, chronic cough, and poorer lung function, especially in children.

  • Effects persist across countries, climates, and housing systems.

  • Evidence is strongest for asthma and allergic respiratory disease, but extends to bronchitis, infections, and symptom burden in people with existing lung disease.

2) Health effects are dose-related, not binary

  • Risk increases with extent, persistence, and visibility of dampness/mould (patch size, odour, condensation, repeated water damage).

  • No safe threshold has been identified → “any dampness matters.”

3) Mental health impacts are now well-established

  • Damp and mould exposure is associated with depression, anxiety, stress, sleep disturbance, and reduced wellbeing.

  • Pathways are both biological (inflammation, immune activation) and psychosocial (lack of control, stigma, housing insecurity).

4) Children are disproportionately affected

  • Strong paediatric evidence links damp homes to asthma development, poorer asthma control, and higher healthcare use.

  • Early-life exposure appears particularly important.

5) Damp housing is a marker of structural inequality

  • Concentrated in low-income, overcrowded, poorly maintained, or privately rented housing.

  • Acts as a health inequality amplifier, not just an environmental exposure.

6) Remediation works—but prevention works better

  • Interventions that fix the building (leaks, insulation, ventilation) improve symptoms.

  • Education alone is insufficient if the housing defect remains.

Thematic synthesis of the literature

1. Respiratory health (strongest evidence base)

Consistent findings across reviews (2016–2025):

  • Dampness and mould exposure increases:

    • Asthma onset in children

    • Asthma severity and exacerbations

    • Wheeze, cough, breathlessness

  • Associations hold even after adjusting for smoking, socioeconomic status, and outdoor pollution.

Key insight

Damp housing is not merely an “asthma trigger” — it is a risk factor for developing disease, especially in childhood.

2. Childhood lung health (very strong, clinically relevant)

  • Paediatric reviews emphasise that clinicians routinely see children whose symptoms are driven or sustained by housing conditions.

  • Poor housing undermines:

    • Controller medication effectiveness

    • Self-management plans

    • Long-term lung development

Clinical implication

Asking about housing conditions should be as routine as asking about pets or smoking in paediatric respiratory clinics.

3. Mental health and wellbeing (rapidly strengthening evidence)

Recent state-of-the-science reviews conclude:

  • Damp and mould exposure is associated with:

    • Depression

    • Anxiety

    • Psychological distress

  • Effects persist even when respiratory disease is accounted for.

Mechanisms proposed

  • Chronic inflammation and immune signalling

  • Sleep disruption

  • Loss of control and “housing stress”

  • Fear for children’s health

Important shift

Damp housing is no longer viewed as purely a respiratory issue—it is a whole-person health exposure.

4. Measurement and exposure assessment (important but imperfect)

What works reasonably well

  • Visual inspection and standard dampness indices

  • Structured questionnaires (especially for asthma cohorts)

  • ERMI (Environmental Relative Moldiness Index) as a research tool

What does NOT yet exist

  • A clinically agreed safe exposure threshold

  • A single test that rules exposure in or out

Consensus

Absence of a perfect test does not mean absence of harm.

5. Built environment, ventilation, and remediation

Clinical trials and housing intervention studies show:

  • Improved ventilation and moisture control:

    • Reduces indoor humidity

    • Improves reported physical and mental health

  • Poorly executed energy efficiency measures can worsen damp if ventilation is not addressed.

Critical point

“Warmth without ventilation” is a known failure mode.

6. Housing as a social determinant of health

Major public health frameworks now explicitly define healthy housing as:

  • Warm

  • Dry

  • Well-ventilated

  • Free from mould and toxins

  • Secure and accessible

Shift in framing

Damp housing is not an individual lifestyle issue—it is a system-level health determinant.

What the evidence does not support (important for countering misinformation)

  • No convincing evidence that:

    • “Detox” supplements treat mould exposure

    • Binding agents reverse health effects

    • Genetic susceptibility alone explains illness without exposure

  • Evidence strongly favours environmental remediation, not biomedical “workarounds”.

Implications for practice, policy, and patient support

For clinicians

  • Ask about damp and mould explicitly.

  • Document housing conditions when symptoms are unexplained or refractory.

  • Support patients with letters or reports—this is evidence-based advocacy, not speculation.

For public health & housing services

  • Damp housing remediation is preventive medicine.

  • Children’s respiratory health and mental health outcomes justify investment.

For patients

  • Symptoms are not imagined.

  • The problem is the building, not personal failure.

  • Improvement often requires structural change, not just treatment escalation.

Bottom line (10-year consensus)

Damp and mouldy housing causes avoidable disease, worsens inequality, and undermines medical care.
Fixing homes is one of the most effective—and underused—public health interventions available.

References

  1. Bentley R, Mason K, Jacobs D, Blakely T, Howden-Chapman P, Li A, Adamkiewicz G, Reeves A.
    Housing as a social determinant of health: a contemporary framework. Lancet Public Health. 2025;10(10):e855–e864. doi:10.1016/S2468-2667(25)00142-2. PMID: 40953578.

  2. Moorcroft C, Whitehouse A, Grigg J.
    Damp and mouldy home: impact on lung health in childhood. Archives of Disease in Childhood. 2025;110(6):419–421. doi:10.1136/archdischild-2023-326035. PMID: 39814530.

  3. Gatto MR, Mansour A, Li A, Bentley R.
    A state-of-the-science review of the effect of damp- and mold-affected housing on mental health. Environmental Health Perspectives. 2024;132(8):086001. doi:10.1289/EHP14341. PMID: 39162373.

  4. Patti MA, Henderson NB, Phipatanakul W, Jackson-Browne M.
    Recommendations for clinicians to combat environmental disparities in pediatric asthma. Chest. 2024;166(6):1309–1318. doi:10.1016/j.chest.2024.07.143. PMID: 39059578.

  5. Punyadasa D, Adderley NJ, Rudge G, Nagakumar P, Haroon S.
    Self-reported questionnaires to assess indoor home environmental exposures in asthma patients: a scoping review. BMC Public Health. 2024;24:2915. doi:10.1186/s12889-024-20418-8. PMID: 39434085.

  6. Kozajda A, Miśkiewicz E.
    Exposure to bioaerosol in the residential environment. Medycyna Pracy. 2024;75(6):545–560. doi:10.13075/mp.5893.01508. PMID: 39688367.

  7. Vesper SJ.
    The development and application of the Environmental Relative Moldiness Index (ERMI). Critical Reviews in Microbiology. 2025;51(2):285–295. doi:10.1080/1040841X.2024.2344112. PMID: 38651788.

  8. Nabaweesi R, Hanna M, Muthuka JK, Samuels AD, Brown V, Schwartz D, Ekadi G.
    The built environment as a social determinant of health. Primary Care. 2023;50(4):591–599. doi:10.1016/j.pop.2023.04.012. PMID: 37866833.

  9. Grant TL, Wood RA.
    The influence of urban exposures and residence on childhood asthma. Pediatric Allergy and Immunology. 2022;33(5):e13784. doi:10.1111/pai.13784. PMID: 35616896.

  10. Coulburn L, Miller W.
    Prevalence, risk factors and impacts related to mould-affected housing: an Australian integrative review. International Journal of Environmental Research and Public Health. 2022;19(3):1854. doi:10.3390/ijerph19031854. PMID: 35162876.

  11. Wimalasena NN, Chang-Richards A, Wang KI, Dirks KN.
    Housing risk factors associated with respiratory disease: a systematic review. International Journal of Environmental Research and Public Health. 2021;18(6):2815. doi:10.3390/ijerph18062815. PMID: 33802036.

  12. Ali SH, Foster T, Hall NL.
    The relationship between infectious diseases and housing maintenance in Indigenous Australian households. International Journal of Environmental Research and Public Health. 2018;15(12):2827. doi:10.3390/ijerph15122827. PMID: 30545014.

  13. Wolkoff P.
    Indoor air humidity, air quality, and health – an overview. International Journal of Hygiene and Environmental Health. 2018;221(3):376–390. doi:10.1016/j.ijheh.2018.01.015. PMID: 29398406.

  14. Mendell MJ, Kumagai K.
    Observation-based metrics for residential dampness and mold with dose–response relationships to health: a review. Indoor Air. 2017;27(3):506–517. doi:10.1111/ina.12342. PMID: 27663473.

  15. Francisco PW, Jacobs DE, Targos L, Dixon SL, Breysse J, Rose W, Cali S.
    Ventilation, indoor air quality, and health in homes undergoing weatherization: a randomized trial. Indoor Air. 2017;27(2):463–477. doi:10.1111/ina.12325. PMID: 27490066.

  16. Barnes CS, Horner WE, Kennedy K, Grimes C, Miller JD.
    Home assessment and remediation. Journal of Allergy and Clinical Immunology: In Practice. 2016;4(3):423–431.e15. doi:10.1016/j.jaip.2016.01.006. PMID: 27157934.

  17. Chew GL, Horner WE, Kennedy K, Grimes C, Barnes CS, Phipatanakul W, Larenas-Linnemann D, Miller JD.
    Procedures to assist health care providers to determine when home assessments for potential mold exposure are warranted. Journal of Allergy and Clinical Immunology: In Practice. 2016;4(3):417–422.e2. doi:10.1016/j.jaip.2016.01.013. PMID: 27021632.

  18. Vesper S, Wymer L.
    The relationship between Environmental Relative Moldiness Index values and asthma. International Journal of Hygiene and Environmental Health. 2016;219(3):233–238. doi:10.1016/j.ijheh.2016.01.006. PMID: 26861576.

by GAtherton

How to Ask Fewer, Better Questions in Appointments

Focusing on what matters most to you—without feeling you’re wasting time

Many patients and carers worry about “asking too much” in clinic. Appointments are short, clinicians are busy, and you may already have a long list of questions in your head. The aim isn’t to stop asking questions—it’s to ask the right ones, at the right time, in the right way.

Here are practical strategies that help you stay focused, feel heard, and make the most of limited time.

1. Decide your Top 3 priorities before you go

Before the appointment, write down everything you’re thinking about. Then circle just three things that matter most right now.

Good priorities are usually:

  • A symptom that is new, worsening, or frightening

  • A treatment issue that affects daily life (side-effects, adherence, cost, function)

  • A decision you need to make soon

If it doesn’t change what happens in the next few weeks, it may not need airtime today.

If you remember only one thing: appointments are for decisions, not encyclopaedias.

2. Separate “need to know” from “nice to know”

It’s easy to mix curiosity with urgency.

Need to know (ask now):

  • Is this symptom important?

  • Is this treatment still right for me?

  • What should I do if X happens?

  • Are we monitoring the right things?

Nice to know (park for later):

  • Mechanisms, pathways, emerging research

  • Rare side-effects without symptoms

  • “What if” scenarios far in the future

Keep a “parking list” for later reading or discussion.

3. Frame questions around impact, not theory

Clinicians work best when questions are grounded in real life.

Instead of:

  • “I read a paper saying X might affect Y…”

Try:

  • “I’m noticing X in daily life—does that change what we do?”

  • “Is this symptom something you’d want to investigate?”

This signals relevance and helps clinicians triage quickly.

4. Ask one question at a time

Long, multi-part questions feel overwhelming and are easy to partially answer.

Break them down:

  • First: Is this important?

  • Then (if yes): What do we do about it?

  • Then (if needed): What should I watch for?

You’ll often find later questions become unnecessary once the first is answered.

5. Use the “Is this something we should…” test

This single phrase keeps questions concise and respectful of time:

  • “Is this something we should investigate?”

  • “Is this something that changes treatment?”

  • “Is this something I should worry about?”

A clear yes/no (or not yet) is often all you need.

6. Accept that not everything fits in one appointment

It’s okay—and normal—to say:

  • “I know we may not have time today—what should I prioritise?”

  • “Which of these matters most from your point of view?”

This shows partnership, not passivity.

If something needs more time, ask how best to handle it:

  • Another appointment

  • A nurse specialist

  • Written advice

  • Monitoring and review later

7. Bring written notes (but don’t read them all out)

A short list helps you stay focused under pressure.

Tip:

  • Highlight your top 3

  • Tick them off as they’re addressed

  • If time runs out, you still covered what mattered most

8. For carers: ask on behalf, not over

Carers often worry about dominating the conversation.

Helpful approaches:

  • Ask the patient first: “What do you most want answered today?”

  • Step in only if something important is being missed

  • Offer to follow up questions outside the appointment if possible

9. Reassure yourself: clinicians don’t expect perfection

You are not expected to:

  • Understand everything

  • Ask the “right” questions every time

  • Cover your entire condition in one visit

Good clinicians prefer:

a focused conversation
over
a rushed, overloaded one

10. A simple closing question that saves time

If time is tight, end with:

  • “Is there anything you think I should have asked but didn’t?”

This often surfaces the most important point of all.

The takeaway

You are not wasting time by asking questions—you’re wasting time by asking too many unfocused ones.

Clarity, prioritisation, and relevance help everyone:

  • You leave with answers that matter

  • Clinicians can make better decisions

  • Anxiety is reduced, not fuelled

by GAtherton

Does when I eat cause fat gain if I have adrenal insufficiency?

Many people with adrenal insufficiency worry that eating at the “wrong time” — especially later in the day — will automatically cause weight gain or “steroid belly”.
This is understandable, but it’s important to separate myths from what actually happens in the body.

https://cdn.media.amplience.net/i/dexcom/stelo-bg-levels-graph?fmt=auto&qlt=default&w=2000
https://www.zrtlab.com/media/3286/1-normal-cortisol-curve-2024.png?height=267&mode=max&width=357

What doctors mean by “glucose response”

When clinicians or researchers talk about glucose response, they mean:

How your blood sugar rises and falls after eating

It does not mean that sugar is instantly being turned into fat.

A rise in blood glucose after eating is normal and happens in everyone.

Does eating later in the day automatically turn food into fat?

No.

Fat gain does not happen because of a single meal or snack — or because you ate at a particular time.

In most people:

  • Carbohydrates are first used for energy

  • Extra glucose is stored as glycogen in muscles and liver

  • Only repeated excess intake over time contributes to fat gain

Eating in the evening does not automatically cause fat storage.

Where insulin fits in (without the fear)

Eating raises blood glucose, which triggers insulin.

Insulin:

  • Helps move glucose into cells

  • Replenishes energy stores

  • Temporarily pauses fat burning

This pause is normal and reversible.
Insulin does not automatically create body fat.

Fat gain happens when:

  • Total calorie intake is consistently higher than needs

  • Steroid replacement is higher than required

  • This pattern continues over weeks or months

Why people with adrenal insufficiency feel confused about this

With adrenal insufficiency:

  • Cortisol replacement is taken in doses, not continuously

  • Symptoms, stress, poor sleep, or illness can affect appetite and energy

  • Some people are prone to low blood sugar, especially later in the day

Because of this:

  • Rigid food timing rules can make symptoms worse

  • Skipping meals or avoiding evening snacks can increase fatigue, dizziness, or night-time symptoms

A safer way to think about meal timing

Instead of strict rules, think in patterns:

  • Some people feel best with:

    • Larger meals earlier in the day

    • Lighter evenings

  • Others need:

    • A small evening snack

    • Protein or fat to keep blood sugar stable overnight

Both can be correct.

What matters most is:

  • How you feel

  • Whether your energy is stable

  • Whether sleep and symptoms improve

What usually matters more than timing

For people with adrenal insufficiency, weight changes are most often related to:

  • Total daily steroid dose

  • Repeated or prolonged stress dosing

  • Reduced activity due to illness or fatigue

  • Menopause, ageing, or other medical conditions

Food timing plays a much smaller role.

Key reassurance

If a food timing rule makes you feel worse, it is not the right rule for you.

  • A single glucose rise does not cause fat gain

  • Eating later does not automatically lead to weight gain

  • Safety, symptom control, and adequate steroid replacement come first

Please remember

Never change steroid dose or meal patterns intended to prevent hypoglycaemia without medical advice.
Underdosing steroids is far more dangerous than eating at the “wrong” time.

Take-home message

Focus on stability, nourishment, and feeling well — not fear of timing.

by GAtherton

Hydrocortisone dosing in adrenal insufficiency

Why adrenal insufficiency can happen in people with aspergillosis

Many people with aspergillosis, particularly those with asthma-related conditions such as allergic bronchopulmonary aspergillosis (ABPA) or more severe chronic lung disease, need treatment with steroid medicines at some point. These treatments — often essential to control inflammation, protect the lungs, and improve breathing — may include repeated or long-term courses of steroids such as prednisolone.

When steroid treatment is used over time, it can reduce the body’s own production of cortisol by the adrenal glands. In some people, the adrenal glands do not fully recover, leading to adrenal insufficiency. Cortisol is a vital hormone that helps the body manage energy, illness, infection, and physical stress. When it cannot be made reliably, hydrocortisone replacement is needed to keep the body safe and functioning.

In this situation, hydrocortisone is prescribed to replace the cortisol your body can no longer make, usually after prednisolone has been reduced or stopped, or when prednisolone is no longer needed to control lung inflammation but adrenal support is still required.

Adrenal insufficiency in people with aspergillosis is not a failure and not something you have caused. It is a recognised consequence of necessary treatment for a serious, long-term condition. With the right information, a personalised dosing plan, and medical support, adrenal insufficiency can be managed safely alongside aspergillosis.

A patient guide to everyday (basal) dosing, higher-dose needs, and short-term stress dosing

If you take hydrocortisone because you have adrenal insufficiency, understanding how your dose works — both day to day and during illness or stress — is essential for your safety and wellbeing.

This guide explains:

  • What your basal (everyday) dose is for

  • Why some people need higher basal doses

  • When and how stress dosing is used — and why it is short term

  • Why some doctors may hesitate — and how to work safely with them

  • Where to find trusted patient and clinician resources

Very important first point ❗

Any changes to your hydrocortisone dose must be agreed in advance with a doctor or specialist nurse who knows your adrenal insufficiency.

This includes:

  • Your usual daily dose

  • Your stress-dosing (“sick day”) plan

  • Emergency injection instructions

This guide does not replace medical advice.
It is designed to help you understand your treatment and communicate clearly with healthcare professionals.

1) Your basal (everyday) hydrocortisone dose

What the basal dose is for

Your basal dose is the hydrocortisone you take on an ordinary day, when you are not ill or under unusual stress. Its purpose is to:

  • Replace the cortisol your body cannot make reliably

  • Support normal daily function (energy, blood pressure, mood)

  • Help your body feel stable and safe

  • Reduce the risk of chronic under-replacement

It is replacement, not treatment for inflammation.

A key point many patients are not told

Being consistently under-replaced does not help adrenal recovery.

Ongoing symptoms such as:

  • Constant exhaustion

  • Dizziness or nausea on standing

  • Brain fog or low mood

  • Poor tolerance of everyday stress

  • Frequent “crashes” or infections

can delay recovery, not speed it. Stability supports healing.

What doctors usually mean by a “physiological” dose

Most adults naturally produce the equivalent of about 15–25 mg of hydrocortisone per day.

Doctors aim for a dose in this range and adjust for:

  • Body size

  • Activity level

  • Other medical conditions

  • Individual response

This is replacement, not “high-dose steroids”.

How basal hydrocortisone is usually taken

To mimic the body’s natural rhythm, doses are often split:

  • A larger dose in the morning

  • Smaller doses later in the day

  • Avoiding late evening doses where possible

This supports:

  • Energy and blood pressure

  • Sleep

  • Mood and concentration

Signs your basal dose may be too low

Tell your doctor if you have persistent:

  • Severe fatigue despite rest

  • “Wired but empty” feeling

  • Dizziness, nausea, or salt craving

  • Poor concentration or memory

  • Low mood or anxiety

  • Frequent need for rescue or stress doses

These symptoms matter even if blood tests look reassuring.

Blood tests are only part of the picture

Cortisol and ACTH tests:

  • Help with diagnosis

  • Are less helpful for adjusting daily dose

  • Do not always reflect how well you function

Doctors experienced with adrenal insufficiency rely heavily on how you feel and cope day to day.

The right balance

Rather than “as low as possible,” a safer aim is:

Low enough to avoid overtreatment, but high enough to live a stable, functional life.

Living in constant deficit is not success.

2) When a higher basal dose may be appropriate

Some people with adrenal insufficiency — particularly those with chronic illness — may genuinely need a higher basal hydrocortisone dose (for example 25–30 mg/day).

This does not automatically mean overtreatment.

Well-recognised examples include:

Chronic inflammatory lung disease (including ABPA)

  • Ongoing airway inflammation and immune activation

  • Recurrent infective or inflammatory flares

  • The body may never be in a true “resting” state

  • Standard doses may leave patients under-replaced

  • A stable higher dose can reduce repeated stress dosing and improve daily function

Frequent infections or slow recovery

  • Repeated illness or prolonged recovery

  • Frequent “temporary” stress dosing just to cope with everyday life

Long-standing steroid-induced adrenal insufficiency

  • Years of prednisolone or similar treatment

  • Deep suppression of the adrenal system

Larger body size or higher metabolic demand

  • Cortisol needs vary with body size and activity

Autonomic symptoms or low blood pressure

  • Postural dizziness or faintness

  • Often benefit from a higher morning dose

Clinical clue:
If someone repeatedly needs stress dosing just to manage ordinary days, their basal dose may be too low for their current physiology.

Important reassurance

  • Higher basal doses can be appropriate, temporary, or longer-term

  • They do not automatically prevent recovery

  • Ongoing inflammation and repeated physiological stress suppress recovery more than adequate replacement

  • Doses should always be prescribed, documented, and reviewed

3) Stress dosing — when your body temporarily needs more

What stress dosing means

A healthy body automatically makes more cortisol during:

  • Illness or infection

  • Fever

  • Vomiting or diarrhoea

  • Injury or trauma

  • Severe pain

  • Surgery or medical procedures

  • Major physical stress

If you have adrenal insufficiency:
➡️ your body cannot do this, so doctors prescribe stress dosing in advance as part of your safety plan.

Stress dosing is essential — but it is short term

Stress dosing is meant to last only as long as the stress lasts.

It covers a temporary increase in need, not your everyday requirements.

What “short term” usually means

Stress dosing may last:

  • 24–48 hours for minor illness or fever

  • Several days for infections or recovery from injury

  • During and immediately after surgery or procedures

Your doctor should advise:

  • When to increase

  • How much to increase

  • When and how to return to your usual dose

Why stress dosing should not continue indefinitely

If higher doses are needed for longer, something usually needs review:

  • Infection or inflammation has not settled

  • The basal dose may be too low

  • Another medical problem is present

If stress dosing is still needed after the original stress has passed, it’s time to talk to your doctor.

Stepping back down safely

  • Doctors usually advise returning to baseline

  • Sometimes a 1–2 day step-down is used

  • You should not remain on stress doses “just in case”

Stress dosing does NOT:

  • Stop adrenal recovery

  • Mean you are “failing”

  • Cause long-term harm when used correctly

Not stress dosing can:

  • Make you seriously unwell

  • Delay recovery

  • Lead to adrenal crisis

https://imgv2-2-f.scribdassets.com/img/document/448471171/original/772be76848/1?v=1
https://www.endocrinology.org/media/3705/nhs-steroid-card-front.jpg?format=webp&quality=20&width=700

4) Why some doctors seem hesitant

Doctors outside endocrinology (GPs, A&E, ward teams):

  • Are trained to minimise steroid use

  • Often think of steroids only as anti-inflammatory drugs

  • May rarely manage adrenal insufficiency

What they may not realise immediately:

Your hydrocortisone is replacing a missing hormone — it is essential, not extra.

5) How to advocate safely (with medical backing)

It is appropriate to say:

“I have adrenal insufficiency. My doctor has advised stress dosing during illness to prevent adrenal crisis.”

If you have them, show:

  • Your Steroid Emergency Card

  • A written stress-dosing plan

  • A clinic letter or summary

6) Trusted resources & further support (with links)

The following organisations provide reliable, clinician-endorsed information on adrenal insufficiency, hydrocortisone replacement, stress dosing, and emergency care.
They are widely recognised by NHS endocrinology teams and safe to share with patients, families, and healthcare professionals.

UK patient and professional resources

Addison’s Disease Self-Help Group (ADSHG)
Website: https://www.addisonsdisease.org.uk

What it offers:

  • Clear explanations of basal vs stress dosing

  • Patient-friendly sick-day rules

  • Emergency hydrocortisone injection guidance

  • Downloadable patient leaflets used in NHS clinics

  • Webinars, helpline, and peer support

Why it’s useful:
ADSHG explicitly supports individualised dosing and crisis prevention.

Society for Endocrinology
Steroid Emergency Card & adrenal crisis guidance:
https://www.endocrinology.org/clinical-practice/steroid-emergency-card/

Why it’s useful:

  • Highly trusted by doctors, A&E, and ward teams

  • Clear professional wording that reassures non-specialists

  • Supports rapid decision-making in emergencies

NHS (England)
Steroid Emergency Card information:
https://www.nhs.uk/conditions/steroid-emergency-card/

Why it’s useful:

  • Official NHS backing

  • Useful for legitimacy in emergency or inpatient settings

International patient resources (useful supplements)

Endocrine Society
Patient information on adrenal insufficiency:
https://www.endocrine.org/patient-engagement/endocrine-library/adrenal-insufficiency

Why it’s useful:

  • Clear explanations of cortisol physiology

  • Conservative, authoritative tone

  • Helpful for patients seeking international consensus

National Adrenal Diseases Foundation (NADF)
Website: https://www.nadf.us

What it offers:

  • Practical sick-day rules

  • Emergency preparedness guidance

  • Injection training resources

Particularly helpful for patients with long-standing adrenal insufficiency or frequent illness.

Resources especially relevant for ABPA & chronic lung disease

National Aspergillosis Centre
Website: https://mft.nhs.uk/wythenshawe/services/infectious-diseases/national-aspergillosis-centre/

Why it’s relevant:

  • Specialist centre where ABPA and adrenal insufficiency often overlap

  • Supports personalised care plans in complex disease

Aspergillosis Trust
Website: https://www.aspergillosistrust.org

Why it’s useful:

  • Patient-focused education and advocacy

  • Helps explain the chronic physiological stress of ABPA

  • Supports conversations about higher basal hydrocortisone needs

Quick-access patient checklist (phone / wallet)

Patients are encouraged to keep:

  • Steroid Emergency Card

  • Sick-day rules (ADSHG)

  • Personal stress-dosing plan (agreed with doctor)

  • Clinic letter or summary

Many patients keep photos of these documents on their phone for emergencies.

Final reassurance

These resources support — not replace — medical advice.
They exist to help patients stay safe, informed, and confident when managing hydrocortisone and communicating with healthcare professionals.

by GAtherton

**Pain Perception and Aspergillosis:

Why It Matters — and What Help Is Available**

Living with aspergillosis—whether Chronic Pulmonary Aspergillosis (CPA), Allergic Bronchopulmonary Aspergillosis (ABPA), Aspergillus bronchitis, or Severe Asthma with Fungal Sensitivity (SAFS)—can mean coping with symptoms that change day to day.
Pain, breathlessness, muscle aches, fatigue and joint discomfort are common. What many people don’t realise is that how the body perceives and processes pain plays a major role in how these symptoms feel — and how well they can be managed.

Understanding pain perception doesn’t mean your symptoms aren’t real. It means understanding why pain behaves the way it does in chronic illness — and how to gain more control.

1. Why pain perception matters in aspergillosis

Pain is produced by the nervous system, and is influenced by:

  • Inflammation in the lungs or sinuses

  • Muscle strain from coughing or altered breathing

  • Reduced fitness after flare-ups

  • Long-term corticosteroid use

  • Adrenal insufficiency

  • Stress, uncertainty, poor sleep, and emotional load

Pain is therefore a mix of bodily changes and how the brain interprets signals.
Both are real. Both deserve attention.

2. Muscle changes and increased sensitivity

People with aspergillosis may experience:

  • Weakened rib, back, and shoulder muscles

  • Reduced leg strength

  • Joint instability

  • Muscle fatigue leading to higher pain sensitivity

Everyday movements can feel more painful, and pain can worsen breathlessness. Many people fall into a cycle: flare-up → rest → muscle weakening → more pain → more breathlessness → more rest.

Understanding this cycle helps break it.

3. Stress, sleep and emotions influence pain

Pain becomes stronger when:

  • You are tired

  • You feel anxious, unsafe, or overwhelmed

  • Your symptoms are unpredictable

  • You have recently been in hospital

  • You are caring for someone who is unwell

This does not mean pain is psychological.
It means the nervous system becomes more alert, so signals feel louder.

Carers experience this too.

4. Why understanding pain helps you manage symptoms

Learning about pain perception helps you:

  • Pace activity wisely

  • Avoid panic when symptoms spike

  • Identify muscular vs inflammatory discomfort

  • Communicate clearly with clinicians

  • Reduce stress-driven symptom amplification

  • Prevent flare-ups by calming the nervous system

It’s not about ignoring symptoms — it’s about understanding them so you can respond safely and confidently.

5. NHS resources that can help

Below are useful links recommended across NHS pain services.

🔹 NHS self-help guidance on long-term pain

These pages offer practical advice on managing persistent pain, pacing, movement, and everyday strategies:

How to get NHS help for your pain
https://www.nhs.uk/live-well/pain/how-to-get-nhs-help-for-your-pain/

10 ways to reduce pain
https://www.nhs.uk/live-well/pain/10-ways-to-ease-pain/

These guides are suitable for people with chest pain, muscular pain, fatigue and inflammation linked to lung disease.

🔹 NHS Pain Management Programmes (PMP)

Many NHS Trusts run Pain Management Programmes. These provide a combination of physiotherapy, psychology, pacing education, flare-up planning, and medication review.

Examples of NHS PMP resources:

Royal Orthopaedic Hospital – PMP information
https://roh.nhs.uk/services-information/pain-management/pain-management-programme

Ashford & St Peter’s Hospitals – Pain Management Programme
https://www.ashfordstpeters.nhs.uk/the-pain-management-programme

Gloucestershire Hospitals – Pain Management Options
https://www.gloshospitals.nhs.uk/our-services/services-we-offer/pain-management-service/management-options-pain/

Speak to your GP or specialist team if you want a referral.

🔹 The Pain Toolkit (NHS-endorsed self-management booklet)

Widely used by NHS pain services and physiotherapy teams.

PDF:
https://www.nhsfife.org/media/c349s6xo/nhs-fife-pain-toolkit.pdf

This guide covers pacing, flare-up planning, problem-solving, emotional wellbeing and shared decision-making.

🔹 NHS Talking Therapies (for stress-related pain amplification)

If stress, anxiety or sleep disturbance are worsening your pain, NHS Talking Therapies services can help.

Find your local service here:
https://www.nhs.uk/service-search/mental-health/find-a-psychological-therapies-service/

These services support people with long-term physical conditions as well as mood and anxiety problems.

🔹 Physiotherapy & pulmonary rehabilitation

These services help with:

  • Breathing pattern retraining

  • Strengthening ribs, shoulders, back, hips, and knees

  • Improving stamina and reducing breathlessness

  • Reducing muscle pain and improving posture

Ask your GP, respiratory consultant, or specialist nurse for a referral.

6. What patients and carers can start today

✔ Notice pain patterns

Track fatigue, sleep, activity, stress, and symptoms.

✔ Practice pacing

Spread tasks through the day. Avoid pushing hard on “good days” — it often leads to flare-ups.

✔ Gentle strengthening

Even small daily exercises protect joints, support breathing and lower pain sensitivity.

✔ Reduce nervous-system overload

Breathing exercises, grounding, relaxation and mindfulness calm the system that amplifies pain.

✔ Seek help early

If pain changes or worries you, involve your GP or specialist team.

✔ Carers: protect your wellbeing

Carers benefit from pacing, strengthening and psychological support just as much as patients.

7. When to seek medical review

Contact your GP or specialist team urgently if you experience:

  • Sudden new chest pain

  • Pain with fever or coughing up blood

  • Pain that stops you breathing normally

  • Severe muscle weakness

  • Persistent flare-ups despite treatment

  • Symptoms suggesting adrenal problems

Pain in aspergillosis is real, but also manageable. With the right understanding and NHS-supported tools, you can reduce flare-ups, regain confidence, and improve daily life.

by GAtherton

Why do some people with aspergillosis lose weight on the hips and thighs, but gain around the waist?

Many people living with aspergillosis, bronchiectasis or ABPA notice their body shape changing as they get older — especially after 60.
A very common pattern is:

  • Thinner hips and legs

  • More weight around the waist or tummy

This can feel confusing, but there are clear reasons why it happens.

1. Chronic lung conditions make it harder to keep leg and hip muscle

When you live with a long-term lung condition, you often have:

  • Breathlessness

  • Fatigue

  • Repeated chest infections

  • Less ability to walk long distances or climb stairs

Because the legs work harder than any other muscles, they are the first to lose strength and size when activity drops.
This is why many people notice:

  • Slimmer thighs

  • Smaller hips

  • Feeling weaker when getting out of a chair

This is partly due to age, but it happens faster in people with chronic lung disease.

2. Steroids can move weight from the limbs to the waist

Many aspergillosis patients have had:

  • Several courses of prednisolone over the years

  • High-dose inhaled steroids

  • Hydrocortisone replacement for adrenal problems

Even short or occasional courses can cause fat redistribution, where:

  • Fat and muscle reduce in the arms, hips and legs

  • More fat settles around the stomach area

  • The centre of the body becomes rounder even if the overall weight hasn’t changed much

This effect can continue long after stopping steroids.

3. Ageing naturally shifts fat towards the waist

After about age 60, the body changes how it stores fat:

  • Less around the hips and thighs

  • More around the waist

  • More “internal” fat around organs (visceral fat)

This happens to everyone, but can be more noticeable in people with aspergillosis because illness already reduces leg muscle.

4. You can lose muscle even if weight on the scales stays the same

Many patients say,
“I feel thinner and thicker at the same time.”

That’s because:

  • Muscle in the legs may be lost

  • Fat around the waist may increase

  • The total body weight doesn’t always change much

This is a normal pattern in long-term lung disease.

5. Illness, flare-ups, infections and poor appetite add to this

During flare-ups or infections, it’s common to:

  • Eat less

  • Feel exhausted

  • Lose muscle faster

  • Keep or gain tummy fat

The body burns muscle first when unwell, not fat — especially not tummy fat.

Is this dangerous?

Not usually on its own — but it does mean:

  • Legs may feel weaker

  • Balance and stamina can reduce

  • It may be harder to stay active

Strength and gentle exercise (within your limits) can help rebuild some leg muscle.

If weight changes are sudden or unexplained, they should always be discussed with your GP or specialist.

In summary

This body-shape change is very common in people with aspergillosis over 60.
It’s caused by a combination of:

  • Reduced activity due to breathlessness

  • Loss of leg and hip muscle

  • Steroid effects on fat distribution

  • Natural age-related changes

  • Appetite changes during illness

It doesn’t mean you’re doing anything wrong — it’s simply a pattern seen in many people with long-term lung disease.

by GAtherton

Understanding Mucous Casts in Allergic Bronchopulmonary Aspergillosis (ABPA)

People living with Allergic Bronchopulmonary Aspergillosis (ABPA) often notice thick, unusual mucus coming up during a flare. Some of this mucus can look very different from “normal” sputum and may be described as mucous casts. This leaflet explains what they are, why they happen, and what they mean for your ABPA.

⭐ What are mucous casts?

A mucous cast is a thick, sticky plug of mucus that forms inside your airways.
It takes on the exact shape of the airway or branch it was sitting in – a bit like a soft mould of the inside of your lungs.

When coughed up, casts may look:

  • long and tube-shaped

  • soft and rubbery

  • curled or C-shaped

  • occasionally branching, like a twig

  • pale yellow/cream with darker specks

These darker flecks can include dead inflammatory cells, airway debris, and sometimes tiny amounts of fungal material trapped inside.

⭐ Why do they happen in ABPA?

ABPA is not an infection, but an allergic over-reaction to the Aspergillus fungus.
This allergic inflammation causes:

1. Excess mucus production

Your airways create far more mucus than usual.

2. Thicker, stickier mucus

Inflammation changes the chemistry of the mucus, making it harder to clear.

3. Swollen, narrowed airways

This makes it easy for mucus to get stuck and form plugs.

4. Trapped material

Casts can contain:

  • fungal spores

  • inflammatory cells

  • dust or other inhaled particles

  • old blood or tissue debris

All of this can glue together into a cast.

⭐ Are mucous casts harmful?

They are not dangerous on their own, but they can cause problems:

  • Airway blockage → breathlessness, wheeze, sudden tightness

  • Chest infections → trapped mucus is an ideal place for bacteria

  • ABPA flare-ups → casts often appear during periods of high inflammation

  • Reduced airflow on CT scans → seen as “bronchial impaction”

Telling your clinical team when you notice casts helps them judge how active your ABPA is.

⭐ What do mucous casts look like in ABPA?

Patients often describe:

  • “noodles”

  • “worms”

  • “rubbery plugs”

  • “little branches”

  • “specks of brown/black” within pale mucus

These appearances are normal in ABPA and do not mean your lungs are permanently worsening.

⭐ How are mucous casts managed?

1. Airway clearance

This is the most important step. Techniques include:

  • huff-coughing

  • active cycle of breathing

  • nebulised saline (hypertonic or isotonic)

  • flutter/PEP devices (Acapella, Aerobika)

  • chest physiotherapy

These help loosen and move mucus from deeper airways.

2. Medication

Depending on your treatment plan:

  • inhalers (bronchodilator + inhaled steroids)

  • biologics (e.g., mepolizumab, dupilumab, omalizumab)

  • antifungal medication if prescribed as part of your ABPA care

  • oral steroids if medically appropriate

Biologics can reduce the inflammation that causes casts, so many patients notice fewer plugs over time.

3. Monitoring

Your team may keep an eye on:

  • sputum samples

  • IgE levels

  • CT scan changes

  • symptom patterns

⭐ When should I tell my team?

Contact your clinical team if you notice:

  • more frequent mucous casts

  • sudden breathlessness or chest tightness

  • a drop in your usual oxygen saturation

  • fever or signs of infection

  • coughing up blood

  • a change in colour or smell of mucus

⭐ Reassurance

Mucous casts are very common in ABPA.
They can look alarming, but they are simply a sign that your airways are inflamed and producing thick mucus.

Coughing them out is helpful, not harmful.
It allows the affected airway to reopen and can rapidly improve breathing.

✅ Further Reading

For more patient-oriented information, you can visit the AFIT website where the term “casts” is discussed in the context of aspergillosis: Aspergillus.org.uk – search “casts”.

by GAtherton

🌿 Your Immune System, Biologics, and Steroids: What’s Suppressed — and What Stays Strong

A clear, reassuring guide for people living with ABPA, CPA, asthma, SAFS, or bronchiectasis

Treatments for aspergillosis-related conditions often involve steroids, and more recently, biologics.
Many patients understandably wonder:

  • What do these medicines suppress?

  • Do they affect my ability to fight infection?

  • Why are biologics considered safer than long-term steroids?

  • Which parts of my immune system stay strong?

This guide explains the full picture in simple terms.

🧬 1. Understanding Your Immune System: The Three Layers

Your immune system has three major lines of defence.

⭐ A. Barriers — the first line

These stop pathogens entering in the first place:

  • Skin

  • Mucus in airways

  • Cilia sweeping mucus out

  • Tears, saliva, stomach acid

  • Healthy bacteria (microbiome)

👉 Biologics do NOT affect barriers.
👉 Steroids can weaken skin and airway lining if used long-term.

⭐ B. Innate immunity — fast responders

These act within minutes or hours.

Key cells:

  • Neutrophils → main killers of Aspergillus

  • Macrophages → engulf spores

  • Dendritic cells → show pathogens to T-cells

  • NK cells → kill virus-infected cells

Sensors:

  • Dectin-1 → recognises fungal walls

  • TLRs

  • Complement proteins

👉 Biologics do NOT weaken these.
👉 Steroids weaken several key functions, especially neutrophils and macrophages.

⭐ C. Adaptive immunity — targeted, long-term defence

Slower but specialised.

T-cells:

  • Th1 → fight bacteria/viruses

  • Th17 → major antifungal fighters

  • Th2 → allergic pathways (IgE, eosinophils)

  • Tregs → calm inflammation

B-cells & antibodies:

  • IgG / IgA / IgM → normal infection defence

  • IgE → allergy and ABPA pathway

👉 Biologics only suppress Th2/IgE pathways.
👉 Steroids suppress many T-cell and B-cell functions, not just allergy.

🎯 2. What Biologics Suppress (Targeted & Selective)

Biologics used in ABPA and difficult asthma (omalizumab, mepolizumab, benralizumab, dupilumab, tezepelumab) only turn down allergic inflammation, not infection-fighting immunity.

🔻 A. They suppress:

  • IgE

  • Eosinophils

  • IL-4 / IL-5 / IL-13

  • Type-2 allergic inflammation

  • Mucus hypersecretion (IL-13)

  • TSLP airway alarm signalling

🛡️ B. They do NOT suppress:

  • Neutrophils

  • Macrophages

  • Th1 immunity

  • Th17 antifungal pathways

  • T-cell killing function

  • Antibiotic/cell-mediated defences

  • Complement

  • Dectin-1 fungal recognition

This is why biologics do NOT increase fungal infection risk.

🔥 3. What Oral Steroids Suppress (Broad & Non-Specific)

Oral steroids like prednisolone reduce inflammation everywhere — including places you need for infection defence.

❌ A. They suppress key immune cells

  • Neutrophils → move slower, kill less effectively

  • Macrophages → reduced pathogen killing

  • T-cells → weaker antiviral/antifungal defence

  • B-cells → reduced antibody production

❌ B. They suppress important cytokines

  • IL-1, IL-2, IL-6

  • TNF-α

  • Interferons

  • IL-12, IL-23 (Th1/Th17 pathways)

These are essential for fighting viruses, bacteria, and fungi.

❌ C. They weaken antigen presentation

Dendritic cells and macrophages become less effective at “showing” pathogens to T-cells.

❌ D. They weaken barriers

  • Thinner skin

  • Thinner airway lining

  • Slower wound healing

This increases infection risk.

❌ E. They reduce eosinophils and IgE (similar to biologics)

But they do this alongside suppressing many healthy parts of your immune system.

🛡️ 4. What Remains Intact on Each Treatment

✔ On biologics (strongest preserved immunity):

  • Neutrophil antifungal killing

  • Macrophage function

  • Th1 & Th17 immunity

  • Antibodies (IgG, IgA, IgM)

  • Complement

  • Mucus & cilia defences

  • NK cell antiviral defence

  • Fever & inflammation responses

⚠️ On steroids (weaker preserved immunity):

  • Complement

  • Some antibody production

  • Basic barrier function (though thinner)

Many infection-fighting cells work less effectively.

🫁 5. Why Biologics Are Safer Long-Term for ABPA/SAFS

Because biologics:

  • target only a tiny portion of immunity

  • do not increase fungal growth

  • do not raise infection risk

  • reduce inflammation without broad suppression

  • help avoid long-term steroid complications

Steroids:

  • increase infection risk

  • can worsen fungal colonisation

  • damage lung structure over time

  • cause weight gain, bone thinning, adrenal issues

  • must be used short-term only when essential

🌈 6. Summary Table

Immune Feature Biologics Steroids
IgE suppression ✔ ✔
Eosinophil suppression ✔ ✔
Neutrophils Unaffected Suppressed
Macrophages Unaffected Suppressed
Th1/Th17 antifungal pathways Unaffected Suppressed
Viral defence Unaffected Suppressed
Barrier integrity Unaffected Weakened
Infection risk No increase Increased
Long-term safety High Low

🌟 7. One-Sentence Takeaway

Biologics turn down the allergic part of immunity (IgE, IL-4, IL-5, IL-13, eosinophils), while steroids suppress many of the infection-fighting parts as well — which is why biologics are much safer long-term.

by GAtherton